To evaluate the potential of the expression of the sodium / iodide symporter ( NIS ) as a means of targeting radioiodine to tumor cells, we have employed plasmid -mediated transfection of the NIS gene into a range of mammalian cell hosts. We observed perchlorate -inhibitable iodide uptake up to 41 -fold over control in all NIS -transfected cells. We assessed the effect of NIS expression followed by exposure to 131 I À on the clonogenic survival of UVW glioma cells. After exposure of two -dimensional monolayer cultures of UVW ± NIS cells to 131 I À at a radioactive concentration of 4 MBq / mL, clonogenic survival was reduced to 21%. Similar treatment of UVW ± NIS cells in three -dimensional spheroid cultures resulted in a reduction of clonogenic survival to 2.5%. This increase in sensitivity to 131 I À exposure is likely to be due to a radiological bystander effect. These results are very encouraging for the development of a novel cytotoxic gene -therapy strategy in which a radiological bystander effect plays a significant role in tumor cell sterilization. Cancer Gene Therapy ( 2000 ) 7, 1529 ± 1536
I
onizing radiation is one of the most commonly used, and most efficacious cancer therapies. Radiotherapy has several major advantages over many chemotherapeutic regimes, such as quantitative dosimetry, the relative lack of clonal evolution of resistance, and the absence of``sanctuary sites.'' However, there is generally little difference in the radiosensitivities of tumor and normal cells, and the lack of biological specificity of ionizing radiation results in its use primarily as a treatment for local, macroscopic disease.
Treatment of disseminated micrometastatic disease requires that radiation is delivered selectively to tumor cells, regardless of their location. This necessitates biologically targeted radionuclide strategies. Although many such schemes have been investigated, few form part of therapeutic protocols. Those currently in use include 131 I-metaiodobenzylguanidine therapy for neuroblastoma, and ionic 131 I À administration for differentiated thyroid tumors. Because most well-differentiated thyroid tumors retain iodide-concentrating capacity, sodium radioiodide ( Na 131 I) is used to ablate postsurgical remnants and to treat recurrent and metastatic disease. 1 The overall prognosis following radioiodine therapy is good for differentiated thyroid cancer. This is the most basic, yet most efficacious form of radionuclide therapy to date.
The uptake of iodide by thyroid epithelial cells is due to the expression of the sodium (Na ) and iodide ( I) symporter ( NIS ) gene, a 13 -spanning membrane protein with intrinsic ATPase activity, which is capable of the cotransport of sodium and iodide ions across the cell membrane against a concentration gradient. 2 ± 4 The recent cloning and sequencing of the human HIS gene ( hNIS ) has allowed investigations into the effect of induced NIS expression by nonthyroidal cell types. These studies have shown that NIS expression confers the ability to concentrate iodine in a variety of cell types. 5, 6 Endogenous expression of the hNIS gene has been found primarily in thyroid tissue but also, to a much lower extent, in other secretory and exocrine tissues. 7 These observations indicate that, following thyroid blockade, it may be possible to deliver Na 131 I to transfected, hNIS-expressing, tumor cells with minimal uptake of radioactivity in normal tissues.
The present report describes experiments performed to investigate the effect of hNIS expression on iodide uptake in a nonthyroid cell line, which allowed investigation of the effect of 131 I À uptake on the clonogenic survival of hNIStransduced cells in both two -dimensional monolayer and three -dimensional spheroid models. The three -dimensional model enables the evaluation of radiation crossfire between cells having different levels of radionuclide uptake. Our results demonstrate that hNIS expression followed by 131 
À treatment results in hNIS-dependent cell sterilisation, and that transgenetic expression of hNIS has potential as a novel cancer therapy.
MATERIALS AND METHODS

Cell culture
Four cell lines were used in this study: UVW ( human glioma ), SK -N -MC ( human neuroblastoma ), A2780, and CP70 ( both human ovarian adenocarcinoma) . Cells were maintained in either Eagle's minimal essential medium or RPMI 1640 (Life Technologies, Paisley, UK ) , both supplemented with 10% fetal bovine serum, penicillin / streptomycin (100 U /mL ), fungizone (2 g /mL ), and glutamine (200 mM ) . Cells were cultured at 378C in a 5% CO 2 atmosphere.
Plasmids
The hNIS cDNA inserted into the EcoRI site of the pcDNA3 plasmid ( Invitrogen, DeSchelp, Netherlands ) was kindly provided by Dr. S. M. Jhiang ( Ohio State University, Columbus, OH ) . To create transfection control plasmids, cDNA encoding the jellyfish green fluorescent protein ( GFP ) was subcloned into the HindIII and NotI sites of the pcDNA3 plasmid. In addition, a pcDNA3 plasmid -only control, termed empty vector control, was also used.
Transfection of cell lines
Cells were seeded at 5Â10 3 per well in six -well plates, and allowed to grow to 50% confluence, before being transfected with 3 g plasmid DNA ( hNIS -pcDNA3, GFP -pcDNA3, or pcDNA3 without insert) using Effectine lipid transfection reagent (Qiagen, West Sussex, UK ) according to the manufacturer's instructions. After 24 hours, geneticin G -418 sulphate (0.5 mg /mL ) was added to select for transduced cells. Transfectants were maintained in identical conditions to the parental cells, with the addition of geneticin at each passage.
Iodide uptake studies
Time course and kinetic experiments were performed using the method of Kennel et al. 24 A total of 5Â10 4 were seeded into 24 -well plates containing 0.5 mL of the appropriate incubation medium, and allowed to attach overnight. Medium was then aspirated, and the cells washed in incubation buffer ( phosphate -buffered saline containing 0.1% bovine serum albumin (Sigma, Dorset, UK ) ). Iodide uptake was then initiated by incubation of cells in incubation buffer containing 10 M NaI and 1 Ci /mL Na 125 I (specific activity =100 Ci /mol ). Incubations were carried out at 378C in a 5% CO 2 atmosphere for the times indicated. Studies involving perchlorate -mediated inhibition of iodide uptake were performed in an identical manner, with the exception of the addition of 1 mM NaClO 4 to the incubation buffer.
Iodide uptake was terminated by the removal of the iodide-containing incubation buffer, followed by three rapid washes in ice -cold, iodide -free incubation buffer. Cells were then solubilized by the addition of 0.5 mL lysis buffer (0.1 M NaOH, 1% sodium dodecyl sulfate, 2% NaCO 3 ) and assessed for radioactivity using a gamma counter ( Canberra Packard, Berks, UK ). An aliquot of the radioactive incubation buffer was also counted for determination of specific activity in each experiment.
For kinetic experiments, cells were assessed for iodide uptake after a 5-minute incubation period in buffer containing 10 ±500 M nonradioactive I À . Nonspecific iodide uptake, assessed using parental UVW cells, was subtracted from the total uptake observed using UVW ± hNIS cells. The number of cells per well was determined in each experiment by counting the contents of six additional wells using a Coulter counter ( Coulter Electronics, Buckinghamshire, UK ).
Iodide efflux studies
Cells were plated in an identical manner to that described for uptake studies and incubated in incubation buffer containing 1 Ci /mL Na 125 I and 10 M NaI (specific activity = 100 Ci /mol ) for 1 hour. Radioactive incubation buffer was then removed, and the cells washed as described above. Cells were then incubated in iodide-free incubation buffer, which was removed at various time intervals, and assessed for radioactivity using a gamma counter. Finally, cells were solubilized in lysis buffer and assessed for residual radioactivity.
Assessment of 131 I toxicity by clonogenic assay
Monolayer experiments. UVW, UVW ±GFP, and UVW ± hNIS cells were seeded in 24 -well plates at 5Â10 4 per well, and allowed to attach for 48 hours. Cells were then washed, and incubated in an incubation buffer containing 13.5± 108.1 Ci /mL Na 131 I and 10 M NaI (specific activity = 135± 1080 Ci/ mol ) for 8 hours. Cells were then washed three times in iodide -free incubation buffer, trypsinized, counted, and plated in 25-cm 2 flasks at densities of 200, 500, and 1000 cells per flask in appropriate tissue culture medium. After incubation for 10± 14 days, the medium was removed and the colonies fixed and stained with Carbol Fuchsin (R.A. Lamb, Middlesex, UK ). Colonies containing more than 50 cells were counted using an automated colony counter ( Synoptics, Cambridge, UK ) .
Spheroid experiments. To investigate the contribution ofparticle crossfire to cell kill, a three -dimensional spheroid model was used. Spheroids were grown by continuously stirring 3Â10 6 UVW, UVW± GFP, and UVW ±hNIS cells in Techne stirrer flasks (Techne, Cambridge, UK ). Spheroids of 250-to 300 -m diameter were obtained after 4 ±5 days of growth. Aliquots were transferred to 20-mL universal containers, suspended in 1 mL of incubation buffer containing 13.5± 108.1 Ci /mL Na 131 I and 10 M NaI (specific activity =135 ±1080 Ci /mol ) , and incubated at 378C for 8 hours. Spheroids were then washed in iodide-free incubation buffer, and disaggregated by incubation in trypsin buffer ( phosphate -buffered saline containing 0.25% trypsin, 1 mM EDTA ) for 10 minutes at 378C. The cell suspension was washed three times in iodide-free incubation buffer, and finally passed through a gauge -14 syringe needle to obtain a single-cell suspension. Microscopic examination confirmed that the cell suspension was free from cellular clumps. Trypan Blue exclusion indicated that cell viability was greater than 98%. Cells were then seeded into 25-cm 2 flasks for clonogenic assay, as described above.
RESULTS
Iodide uptake after hNIS transfection
cDNA encoding the human NIS protein was transfected into four cell lines using the eukaryotic expression vector pcDNA3, under the control of the CMV promoter, and selected for the presence of the geneticin -G418 -sulphate resistance gene. Iodide uptake was assessed by incubating cells with 10 M NaI containing trace Na 125 I ( specific activity = 100 Ci /mol ) for 1 hour (Fig 1) . Iodide accumulation by hNIS -transduced cells was 13-to 66-fold higher than nontransfected control cells, and 10 -to 41 -fold higher than control empty vectortransfected cells ( Fig 1) . UVW cells transfected with GFP also failed to accumulate iodide. The presence of 1 mM perchlorate resulted in inhibition of iodide uptake in hNIS -transduced cells by a factor of 12 -to 41 -fold. These results demonstrate hNIS transfection results in specific, perchlorate -inhibitable iodide uptake in a range of cell lines of nonthyroid origin.
Kinetics of iodide uptake and efflux in UVW ± hNIS cells
The rate of iodide influx was measured by incubation of cells with 10 mM NaI containing trace Na 125 I ( specific activity =100 Ci/ mol ) for 5 ± 50 minutes at 378C. Iodide influx into UVW ±hNIS cells was rapid, with half -maximal uptake observed at 3 ± 5 minutes, reaching equilibrium at 20 ± 30 minutes (Fig 2) . UVW ± hNIS cells incubated in the presence of 1 mM perchlorate failed to accumulate iodide. The initial velocity of iodide uptake was measured after 5 minutes incubation with 10 ±500 M NaI containing trace Na 125 I ( specific activity = 0.32± 16 cpm /pmol ) . K m and V max values were calculated using a LineweaverBurk plot 10 (Fig 3 ) . The values obtained are similar to Rate of iodide efflux from UVW ± hNIS cells. Cells were initially incubated in incubation buffer containing 10 M NaI and 1 Ci / mL Na 125 I ( specific activity = 100 Ci / mol ) for 1 hour. Buffer was then replaced with fresh medium, which was removed after 3 ± 27 minutes, and its previously published values for NIS -transfected cell lines. 5, 8, 9 The rate of iodide efflux was also established for UVW ±hNIS cells by incubation of cells with 10 mM NaI containing trace Na 125 I ( specific activity = 100 Ci/ mol ) for 1 hour, followed by replacement of the radioactive incubation buffer with fresh iodide-free buffer. Cells were then incubated at 378C for 3 ±27 minutes, incubation buffer removed, and counted for 125 I À using a gamma counter. Data are presented as a percentage of the maximum observed uptake. Iodide efflux from UVW ± hNIS cells was rapid, with over 50% of the total cellular iodide released within 3 minutes ( Fig 4) .
I
À toxicity assessed by colony -forming assay
The ability of 131 I to sterilize UVW ±hNIS cells was examined by clonogenic assay.
131 I-mediated toxicity was investigated using both two -dimensional monolayer and three -dimensional spheroid models. For the experiments in monolayers, UVW± hNIS cells were treated with incubation buffer containing 0.5 ±4 MBq /mL Na 131 I and 10 mM NaI for 8 hours at 378C. Cells were then washed, counted, and plated for clonogenic assay in triplicate. For the spheroid experiments, spheroids of 250 ±350 m were treated with incubation buffer containing 0.5± 4 MBq /mL Na 131 I and 10 mM NaI for 8 hours. The spheroids were then disaggregated by trypsinisation and washed. Microscopic examination confirmed that the cell suspension was free from cellular clumps. The washing procedure was carried out after disaggregation to eliminate the possibility of differential I À retention between monolayers and spheroids.
After 10 ± 14 days, clusters containing 50 or more cells were scored as colonies. No clonogenic cell kill was observed in the nontransfected UVW cell line, nor in the control UVW ± GFP cell line, indicating that the transfection procedure did not cause an alteration in plating efficiency ( Fig 5 ) . However, in the case of UVW± hNIS cells, which showed a substantial I À uptake ( Fig 1 ) , a dose -dependent reduction in clonogenic capacity was observed.
UVW ±hNIS cells treated with 131 I À showed a greater reduction in clonogenic capacity when treated as spheroids rather than monolayers ( Fig 5b ) . At radioactivity concentrations of 4 MBq/ mL, the clonogenic survival of treated monolayers was 21% whereas the survival of clonogens derived from spheroids exposed to the same activity concentration was only 2.5%. This represents an increase in efficacy of the radiopharmaceutical of 1 log. Once again, no significant cell kill was observed in spheroids consisting of either nontransfected UVW or UVW ± GFP cells.
DISCUSSION
By means of NIS gene transfer we have induced the capacity for active uptake of iodide in human cell lines derived from glioma, neuroblastoma, and ovarian carcinoma. The factors of enhancement of iodide accumulation were 35 -, 41-, and 10 -fold respectively. These values are similar to those achieved by transfection into other mammalian cell lines, 5, 8, 9 and support the notion that transfection of the NIS gene followed by administration of radioiodine could constitute an approach to the therapy of tumors other than thyroid carcinoma. The kinetics of hNIS-mediated iodide uptake were examined in UVW ± hNIS cells, with V max and K m values obtained using the Lineweaver-Burk double reciprocal plot. 10 The K m value obtained in our system (35 M) is comparable to those values previously obtained for the rat thyroid FRTL -5 cell line, and other NIS -transfected nonthyroid cell lines. 5, 8 The rates of both I À influx and efflux were established in UVW ± hNIS cells. We observed both rapid accumulation and egress of I À , with halfmaximal uptake reached at 3 minutes (external I À concentration 10 mM ). Similarly, the intracellular t 1 / 2 of I À was short ( 3 minutes ) after removal of extracellular I À . The maximal uptake of I À and the rate of efflux are not directly comparable to those observed in thyroid epithelium, as organification of the accumulated iodide by the thyroid prevents passive efflux. 11 However, the observed rates of I À uptake and efflux are similar to those observed in other NIStransfected cell lines, 5, 8, 9 again implying that I À uptake is solely dependent on NIS expression.
We also evaluated the effect of 131 I À uptake on the clonogenic survival of UVW ±hNIS cells cultured as monolayers and as multicellular spheroids. The spheroidal three -dimensional structure approximates to that of avascular micrometastases. Although the lack of a vascular system makes spheroids a less good model of solid large tumors, it is also true that xenografts, with their individualistic and friable blood supplies and nonnegligible immunogenicity are likewise unsatisfactory models for such tumors. We envisage that the described combination of gene transfer and radionuclide delivery will be less appropriate for the treatment of large tumor masses than micrometastases, for which spheroids provide better models than xenografts.
Exposure of NIS -transfected UVW glioma cellular monolayers to graded amounts of Na 131 I resulted in a dose -dependent decrease in the survival of clonogens. After treatment with 4 MBq / mL, colony -forming capacity was reduced to 21% of nontransfected controls. However, spheroids composed of hNIS -transfected UVW cells were substantially more susceptible to the lethal effects of 131 Iradiation. For example, 4 MBq /mL of Na 131 I produced an additional log of cell kill compared to the effect observed in monolayers. Spheroids treated with 131 I À were disaggregated before the washing stage, to ensure that there was no differential in I À retention between monolayers and spheroids after the extracellular iodide had been removed. In addition, we observed no alteration in the intrinsic radiosensitivity between parental UVW cells, and UVW cells transfected with either empty vector, GFP, or hNIS, ( SF2 =0.56 0.08, 0.49 0.07, 0.52 0.05, respectively ) .
A frequently observed effect of cell growth in the form of aggregates as opposed to monolayers is an increased resistance to ionising radiation. This well -documented phenomenon, first described by Durand and Sutherland, 15 has been hypothesized to be due to a``contact effect.'' Such an effect has also been implicated in drug resistance ( reviewed by Olive and Durand 16 ) . It has been proposed that the contact effect is facilitated by intercellular communication, which permits spheroids to recover from radiation damage. 17 However, gap junctions appear to play no role in this effect. 18 A more plausible reason for the relative ineffectiveness of ionising radiation treatment of spheroids is a decreased propensity to apoptose. 19 Several attempts have been made to manipulate cell cycle regulatory factors to modulate the apoptotic response in spheroids. These have been reviewed by Santini et al. 20 Whereas spheroids commonly exhibit resistance to external beam irradiation, the enhanced effectiveness of targeted radionuclide treatment in three -dimensional aggregates as opposed to two-dimensional monolayers is supported by theoretical 21 ± 23 and experimental evidence, 12 ± 14,24 which indicates a correlation between decay particle range and optimal size for cure. The relative contributions to this relationship, of direct deposition of decay particle energy in genomic DNA and indirect biologically mediated responses
is not yet known. Our observation of the increased effectiveness of radionuclide treatment of cellular aggregates, compared to the effect on monolayers, is most likely due to the enhanced efficiency of absorbtion of decay energy in three -dimensional cultures. 12 ± 14 However, it is probable that the efficiency of cell killing is governed by a variety of biologically mediated responses.
Alternative methods of targeted delivery of radioactivity to cancer cells involve conjugation of radionuclides to agents that have specific affinity for tumor markers. Gene transfer has been employed to induce tumor cells to express elevated levels of surface antigens, 25, 26 receptors, 27, 28 or transporters 14 to enhance targeting by radiolabeled antibodies, peptides or meta -iodobenzylguanidine, respectively. Unlike these schemes for radionuclide targeting, Na 131 I therapy requires no radiochemical synthetic procedure. Unlike antibodies, radioiodine is nonimmunogenic and has good diffusion properties. Although tumor targeting using radiolabeled antibodies and peptides is still at the experimental stage of development, the administration of Na 131 I is proven to be effective in the eradication or control of thyroid carcinoma. Furthermore, 131 I is lipophilic in its reduced form and hence cannot enter cells that do not express the NIS. However, in common with other investigators, 5 we have observed that iodide, which is actively accumulated by NIStransduced cells, is lost rapidly. We are attempting to increase the retention time of iodine by simultaneous transfection of the NIS gene and the gene encoding thyroid peroxidase. This should result in peroxidase -catalyzed oxidation of accumulated iodine with subsequent incorporation into aromatic groups of protein Ð analogous to the process of thyroid hormone production.
Another attractive feature of the targeting of NISexpressing tumors is the range of therapeutic radioisotopes of iodine, or other halogens, which may be employed ( Table  1 ). The choice of radionuclide will be influenced by the expected intracellular residence time of the radioactivity and the range of crossfire radiation needed to sterilize clumps of tumor cells of different sizes. Although differences in the ionic radii of the various halides appears to affect affinity for the NIS, 29 experimental evidence indicates that the alphaparticle -emitting radiohalogen 211 At, administered in the 33 and has affinity for NIS -expressing tissues. 34 Currently, we are evaluating the uptake and toxicity of Na 211 At in NIS genetransfected cells.
It is most unlikely that gene -therapy technology will achieve 100% transfection of cells in a tumor in situ. Bystander effects are therefore an important requirement for effective gene therapy. Current gene therapy is mostly based on prodrug activation, with bystander effects dependent on gap junctions, which often diminish with tumor progression. 30 Novel systems providing a freely diffusable product are under investigation. 31 The radiological bystander effect resulting from radiation crossfire provides exciting new possibilities, particularly when transfection efficiencies are low. This and other bystander effects require further investigation, for which a suitable experimental model would be very valuable. Very recently, we have developed a modified spheroid system Ð transfectant mosaic spheroids 32 Ð which seem well suited to the experimental investigation of bystander effects. Transfectant mosaic spheroids are formed by coculturing genetransfected and nontransfected ( but otherwise identical ) cells in controlled proportions. This allows the experimental simulation of small tumors in which various proportions of cells have been transfected. Mosaic spheroids are comprised of a patchwork of transfected and nontransfected microregions. The dynamics of formation of mosaic spheroids and the methods of altering the patchwork structure, are now under investigation. The mosaic spheroid model will be used in our proposed investigation of the radiological bystander effect to quantify the effects of radiation crossfire as a function of the proportion of the cells transfected.
In addition to the therapeutic potential of NIS gene transfection, there are also several potential diagnostic and tumor imaging applications for this system. This has been demonstrated previously in a murine xenograft model using 125 
I
À , although such studies remain at a preliminary stage. 5 It may be possible to improve on the sensitivity and resolution of this tumor-detection system by administration of the positron -emitting isotope 124 I À , followed by PET imaging. Such a system would be of great value in specifying conformal beam radiotherapy, in addition to the targeted radiotherapeutic applications outlined in this report. 123 I is another isotope whose current major clinical use is tumor imaging, due to the favorable gamma component of the decay emission. However, 123 I also emits a number of lowenergy, ultra ±short -range Auger electrons, which are extremely genotoxic if able to interact with cellular DNA. A recent report indicated that Auger electron -emitting radionuclides may also be capable of cell kill by means other than bombardment of nuclear DNA. 12 Although the short range of Auger electrons results in the absence of a bystander effect, single-cell toxicity would be of great use in circumstances such as the ex vivo purging of bone marrow or peripheral blood stem cells before autologous rescue, where it is desirable to minimize damage to normal hemopoietic cells.
We envisage that initial clinical applications of NIS transgenetic strategies would involve ex vivo bone marrow purging, or treatment of regionally confined tumors, where radionuclide could be administered without directly involving the systemic circulation.
